Kenvue
Tracked across 9 events · 104 articles · First seen Sep 22, 2025 · Last active Apr 27, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Regulatory
Impact: Kenvue, a spin-off of Johnson & Johnson, is a primary defendant in the United States — Texas lawsuit, accused of deceptively marketing Tylenol and facing claims of liability transfer from Johnson & Johnson. Kenvue's shares fell following the news.
Oct 28, 2025 · 20 articles
Business
Impact: Kenvue is being acquired by Kimberly-Clark for $48.7 billion, providing a significant premium to its shareholders. Kenvue's stock surged after the announcement, despite facing scrutiny over Tylenol and activist investor pressure.
Nov 03, 2025 · 10 articles
Domestic
Impact: Kenvue, the maker of Tylenol, disputed any link between the drug and autism. Its shares fell 7.5% in trading, reducing its market value by about $2.6 billion due to Donald Trump's statements.
Sep 22, 2025 · 6 articles
Business
Impact: Kenvue, formerly Johnson & Johnson's consumer health unit, retained responsibility for talc-related litigation outside the United States and Canada after its spin-off in 2023. It is named as a defendant in the UK lawsuit and maintains that its talc products are safe and asbestos-free.
Oct 16, 2025 · 14 articles
Regulatory
Impact: Kenvue Brands, the parent company of Johnson & Johnson — Neutrogena, issued the recall for the contaminated wipes, facing potential financial and reputational consequences.
Oct 24, 2025 · 9 articles
Domestic
Impact: Kenvue, the manufacturer of Tylenol, strongly disagreed with the suggestion that acetaminophen causes autism, defending the drug's safety and warning of risks from untreated fever or pain.
Sep 22, 2025 · 6 articles
Domestic
Impact: Kenvue, the manufacturer of Tylenol, refuted the claims made by Robert F. Kennedy Jr. and Donald Trump, stating that studies have found no causal link between acetaminophen use during pregnancy and fetal developmental issues.
Oct 09, 2025 · 9 articles
Tech
Impact: Kenvue, the manufacturer of Tylenol (paracetamol), faced a lawsuit regarding alleged links between its product and autism, which was dismissed. The new study supports the safety of its product.
Jan 16, 2026 · 23 articles
American College of Obstetricians and Gynecologists
reliant company
↔
Kenvue
Kenvue relies on the clinical guidelines of the American College of Obstetrician
American College of Obstetricians and Gynecologists
medical authority
↔
Kenvue
The American College of Obstetricians and Gynecologists issues clinical guidelin
NEWSDESK
Track Kenvue live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard